Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 20 | $8,084,469 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 14 Mar 2025 20:18 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 12 Mar 2025 | Sale | 516 | 44.88 | 23,158 | D |
| 07 Mar 2025 17:30 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 05 Mar 2025 | Sale | 9,338 | 44.401 | 414,617 | D |
| 07 Mar 2025 17:30 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 05 Mar 2025 | Sale | 3,162 | 44.9 | 141,974 | D |
| 07 Feb 2025 18:05 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 05 Feb 2025 | Sale | 12,847 | 56.325 | 723,607 | D |
| 07 Feb 2025 18:05 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 05 Feb 2025 | Sale | 5,903 | 56.924 | 336,022 | D |
| 29 Jan 2025 20:43 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 27 Jan 2025 | Sale | 13,812 | 54.76 | 756,345 | D |
| 29 Jan 2025 20:43 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 27 Jan 2025 | Sale | 5,059 | 55.62 | 281,382 | D |
| 29 Jan 2025 20:43 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 27 Jan 2025 | Sale | 12,379 | 56.97 | 705,232 | D |
| 18 Dec 2024 20:52 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 17 Dec 2024 | Sale | 3,800 | 31.098 | 118,172 | D |
| 12 Dec 2024 20:44 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 10 Dec 2024 | Sale | 2,368 | 30.79 | 72,911 | D |
| 12 Dec 2024 20:44 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 10 Dec 2024 | Sale | 2,450 | 31.03 | 76,024 | D |
| 13 Sep 2024 17:11 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 10 Sep 2024 | Sale | 537 | 26.18 | 14,059 | D |
| 13 Jun 2024 18:06 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 11 Jun 2024 | Sale | 2,380 | 22.641 | 53,886 | D |
| 15 Mar 2024 16:42 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 13 Mar 2024 | Sale | 619 | 28.33 | 17,536 | D |
| 18 Dec 2023 20:29 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 14 Dec 2023 | Sale | 514 | 20.76 | 10,671 | D |
| 25 Sep 2023 20:30 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 13 Sep 2023 | Sale | 531 | 50.34 | 26,731 | D |
| 21 Jun 2023 17:46 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 16 Jun 2023 | Sale | 1,413 | 56.2966 | 79,547 | D |
| 21 Jun 2023 17:46 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 16 Jun 2023 | Sale | 27,462 | 55.08 | 1,512,607 | D |
| 21 Jun 2023 17:46 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 16 Jun 2023 | Sale | 49,325 | 54.575 | 2,691,912 | D |
| 15 Jun 2023 21:35 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 13 Jun 2023 | Sale | 509 | 55.16 | 28,076 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)